The study was conducted at Western Psychiatric Institute and Clinic-University of Pittsburgh Medical Center. An investigational new drug application (IND) was submitted to the US Food and Drug Administration and approval was obtained to use Sensoril® in the study because it met FDA-approved safety guidelines. Sixty subjects with bipolar disorder were enrolled in a 8 [...]The post New Clinical Research Demonstrates Superior Efficacy and Safety of Sensoril® Ashwagandha Root and Leaf Extract appeared first on NutraGenesis.